Keywords: Stroke, High-Field MRI, Spectroscopy, Metabolites, Stem Cell Therapy, Neuroinflammation, Preclinical
Goal(s): This work administers extracellular vesicles (EV) derived from human mesenchymal cells (hMSC) to salvage tissue while monitoring recovery and metabolic changes longitudinally using ultra-high field MRI/S.
Approach: T2-W MRI,23Na-CSI, and 1H-MRS were used to quantify lesion reduction, sodium homeostasis and energetic remodeling.
Results: Upon EV treatment, sodium (and to a lesser extent proton) lesions were reduced by day 3, while lactate, creatine and NAA were stabilized compared to control.
Impact: Combined sodium MRI and proton MRS provide a more sensitive and early quantitative metric to evaluate the efficacy of stem cell-derived therapy following ischemia and longitudinal metabolic, ionic and functional recovery. Such methods can evaluate other treatments against different pathologies.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords